Tectonic Therapeutic | AVRO - Ativo Circulante





Ativo Circulante Alterar Data
Akebia Therapeutics USD 229.55M 13.93M 2026-06
Alnylam Pharmaceuticals USD 4.62B 400.86M 2026-06
Celltrion KRW 481.57B 10.97B 2026-03
Cspc Pharmaceutical CNY 22.25B 359.48M 2025-12
Deva Holding AS TRY 9.13B 1.61B 2023-09
Dianthus Therapeutics USD 897.54M 222.37M 2026-06
Divis Laboratories Ltd INR 110.96B 12.53B 2026-03
Gilead Sciences USD 12.53B 6.11B 2026-06
Ionis Pharmaceuticals USD 2.49B 446.73M 2026-06
Kangmei Pharma CNY 6.8B 225.83M 2026-03
Karyopharm Therapeutics USD 126.33M 23.19M 2026-03
Knight Therapeutics CAD 394.84M 5.86M 2025-12
Laboratorios Farma EUR 509.33M 128.63M 2023-12
MacroGenics USD 321.69M 139.16M 2026-06
Malin Corporation EUR 62.6M 26.7M 2024-12
Medical Developments International AUD 33.75M 1.79M 2025-12
Neuren Pharmaceuticals AUD 332.23M 11.98M 2025-12
Organigram Holdings CAD 250.09M 6.46M 2026-03
Ovoca Bio EUR 2.07M 510K 2025-12
Pfizer USD 41.36B 1.46B 2026-06
Pharma Mar EUR 280.95M 7.5M 2026-06
Qiagen NV USD 1.66B 116.37M 2026-06
Roche Holding CHF 35.44B 3.29B 2026-06
Sangamo BioSciences USD 49.89M 12.3M 2025-06
Sanofi EUR 31.52B 1.36B 2026-06
Sarepta Therapeutics USD 2.22B 86.05M 2026-06
Sartorius EUR 1.64B 280M 2026-06
Sino Biopharmaceutical CNY 33.82B 9.13B 2025-06
Takeda JPY 3.15T 59.77B 2026-06
Tilray USD 729.32M 28.18M 2025-09
Zealand Pharma A/S 15.02B 652.12M 2026-03
Zz Pientze Pharmaceu CNY 11.16B 270.46M 2026-06